Abiraterone Acetate in Combination With Tildrakizumab
Clinical trial NCT04458311 · TERMINATED
Trial details
- NCT number
- NCT04458311
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-04-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.